title: Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection.
authors.affiliation: Hospital Ramón y Cajal, Servicio Gastroenterologia, Madrid, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Bárcena
authors.forename: M
authors.initials: M
authors.lastname: Domínguez-Antonaya
authors.forename: A
authors.initials: A
authors.lastname: López-Sanromán
authors.forename: A
authors.initials: A
authors.lastname: Martínez-Turnes
authors.forename: J
authors.initials: J
authors.lastname: Urman
authors.forename: S
authors.initials: S
authors.lastname: del Campo
authors.forename: N
authors.initials: N
authors.lastname: Moreno
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012008:Recurrence; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine